Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 1
2009 1
2017 1
2018 1
2019 1
2021 1
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Denton CP, Del Galdo F, Khanna D, Vonk MC, Chung L, Johnson SR, Varga J, Furst DE, Temple J, Zecchin C, Csomor E, Lee A, Wisniacki N, Flint SM, Reid J. Denton CP, et al. Among authors: csomor e. Rheumatology (Oxford). 2022 Dec 23;62(1):234-242. doi: 10.1093/rheumatology/keac300. Rheumatology (Oxford). 2022. PMID: 35583273 Free PMC article. Clinical Trial.
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study.
Clark KEN, Csomor E, Campochiaro C, Galwey N, Nevin K, Morse MA, Teo YV, Freudenberg J, Ong VH, Derrett-Smith E, Wisniacki N, Flint SM, Denton CP. Clark KEN, et al. Among authors: csomor e. Lancet Rheumatol. 2022 Jun 23;4(7):e507-e516. doi: 10.1016/S2665-9913(22)00094-7. eCollection 2022 Jul. Lancet Rheumatol. 2022. PMID: 36404995 Free PMC article.
Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.
Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF, Csomor E, Sellman BR, Mustelin T, Sleeman MA, de Bruin-Weller MS, Herath A, Drylewicz J, May RD, Hijnen D. Thijs JL, et al. Among authors: csomor e. J Allergy Clin Immunol. 2018 Apr;141(4):1523-1526. doi: 10.1016/j.jaci.2017.12.991. Epub 2018 Feb 2. J Allergy Clin Immunol. 2018. PMID: 29410314 No abstract available.
Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials.
Baker T, Sharifian H, Newcombe PJ, Gavin PG, Lazarus MN, Ramaswamy M, White WI, Ferrari N, Muthas D, Tummala R, Morand EF, Furie R, Vital EM, Chamberlain C, Platt A, Al-Mossawi H, Brohawn PZ, Csomor E. Baker T, et al. Among authors: csomor e. Ann Rheum Dis. 2024 Apr 3:ard-2023-225445. doi: 10.1136/ard-2023-225445. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38569851 Free article.
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.
Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Csomor E, Sellman BR, Mustelin T, Sleeman MA, de Bruin-Weller MS, Herath A, Drylewicz J, May RD, Hijnen D. Thijs JL, et al. Among authors: csomor e. J Allergy Clin Immunol. 2017 Sep;140(3):730-737. doi: 10.1016/j.jaci.2017.03.023. Epub 2017 Apr 13. J Allergy Clin Immunol. 2017. PMID: 28412391
12 results